| Financial Year |
March 31 2023 |
| Monetary Funds |
1,855,752,604.08 |
| Held-for-trading Financial Assets |
200,034,520.55 |
| Notes Receivable |
169,649,551.54 |
| Accounts Receivable |
610,461,115.78 |
| Advances to Suppliers |
3,854,064.60 |
| Other Receivables |
5,757,177.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
574,098,515.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,309,780.83 |
| Total Current Assets |
3,898,224,891.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,578,156,741.46 |
| Under-construction Projects |
575,892,297.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,356,458.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
53,104,645.77 |
| Other Non-Current Assets |
85,835,352.84 |
| Sub-Total of Non-Current Assets |
2,401,345,496.09 |
| Total Assets |
6,299,570,387.12 |
| Short-Term Loans |
100,019,166.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
159,979,984.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,193,245.57 |
| Taxes Payable |
7,898,913.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,029,902.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,032,666.67 |
| Other Current Liabilities |
310,680.70 |
| Sub-Total of Current Liabilities |
421,854,412.59 |
| Long-term Loans |
82,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,078.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
205,694,812.33 |
| Total Liabilities |
627,549,224.92 |
| Paid-In Capital(Or Share Stock) |
829,015,544.00 |
| Capital Surplus |
4,170,685,772.43 |
| Surplus Reserve |
46,029,715.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
626,285,030.28 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,672,021,162.20 |
| Owner's Equity（Stockholder's Equity） |
5,672,021,162.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,299,570,387.12 |
